OIP5 and hepatocellular carcinoma: Notably, OIP5 has been previously reported to be highly expressed in various cancers, including CRC, hepatocellular carcinoma, renal cell carcinoma, bladder cancer, breast cancer, and glioma [33,34,35,36,37,38].